Does Rallies show 13F holders for SKIN?

Yes. Rallies tracks hedge fund and 13F ownership data for SKIN, including fund names, share counts, latest tracked quarter, and position changes when available.

Is SKIN research on Rallies investment advice?

No. Rallies provides research, data, and educational context for SKIN. It does not provide personalized investment advice.

SKIN (SkinHealth Systems Inc. Class A Common Stock) Stock Analysis - Hedge Fund Holdings

SkinHealth Systems Inc. Class A Common Stock (SKIN) is a publicly traded Consumer Defensive sector company. As of May 21, 2026, SKIN trades at $0.65 with a market cap of $78.49M and a P/E ratio of -13.92. SKIN moved +4.00% today. Year to date, SKIN is -51.95%; over the trailing twelve months it is -59.91%. Its 52-week range spans $0.55 to $2.69. Analyst consensus is neutral with an average price target of $1.63. Rallies surfaces SKIN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns SKIN stock?

Hedge funds tracked by Rallies that own SKIN include Bridgewater Associates, Panagora Asset, and Pinebridge Investments. The latest tracked quarter is Mar 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for SkinHealth Systems Inc. Class A Common Stock.

SKIN Key Metrics

Key financial metrics for SKIN
Metric	Value
Price	$0.65
Market Cap	$78.49M
P/E Ratio	-13.92
EPS	$-0.05
Dividend Yield	0.00%
52-Week High	$2.69
52-Week Low	$0.55
Volume	1
Avg Volume	0
Revenue (TTM)	$296.12M
Net Income	$-6.05M
Gross Margin	64.91%

Top Hedge Funds Holding SKIN

Bridgewater Associates holds 188.50K shares of SKIN, changed -13.91% as of Mar 31, 2024.
Panagora Asset holds 158.95K shares of SKIN, changed +0.00% as of Mar 31, 2026.
Pinebridge Investments holds 1.59K shares of SKIN, changed +0.00% as of Jun 30, 2023.

Latest SKIN News

SkinHealth Systems Q1 Revenue Falls 6.7% to $64.9M; Adjusted EBITDA Rises 16% — May 7, 2026
SkinHealth Systems Rebrands with Focus on 36,000-Device Installed Base and Clinical Rigor — Apr 22, 2026
BeautyHealth 2025 EBITDA Soars to $45.1M as Margins Expand, Sales Slump — Mar 12, 2026

Recent SKIN Insider Trades

Gruber Desiree sold 14.66K (~$22.02K) on Nov 20, 2024.
SAUNDERS BRENT L bought 40.45K (~$43.69K) on Aug 12, 2024.

SKIN Analyst Consensus

5 analysts cover SKIN: 0 strong buy, 1 buy, 3 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $1.63.

Common questions about SKIN

Who owns SKIN stock?: Hedge funds tracked by Rallies that own SKIN include Bridgewater Associates, Panagora Asset, and Pinebridge Investments. The latest tracked quarter is Mar 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for SkinHealth Systems Inc. Class A Common Stock.
Does Rallies show 13F holders for SKIN?: Yes. Rallies tracks hedge fund and 13F ownership data for SKIN, including fund names, share counts, latest tracked quarter, and position changes when available.
Is SKIN research on Rallies investment advice?: No. Rallies provides research, data, and educational context for SKIN. It does not provide personalized investment advice.